Health equity

Liviniti Announces CEO LeAnn Boyd Named to Modern Healthcare's Women Leaders 2024 List

Retrieved on: 
Monday, March 11, 2024

Program honors women executives who influence care delivery and policy

Key Points: 
  • Natchitoches, Louisiana--(Newsfile Corp. - March 11, 2024) - Liviniti is proud to announce that LeAnn Boyd, CEO, has been recognized by Modern Healthcare as one of its Women Leaders for 2024.
  • As CEO and Co-founder of Liviniti, LeAnn has long challenged the pharmacy industry to adopt practices that make prescription drugs more affordable and accessible.
  • I am honored to be among the group of exceptional women named to Modern Healthcare's Women Leaders, 2024."
  • LeAnn C. Boyd, PharmD - CEO and Founder Wire Industry: Healthcare & Pharmaceutical
    To view an enhanced version of this graphic, please visit:

Unite Us and Foothold Technology Enter Into Strategic Partnership to Enhance Coordinated Care Accessibility in New York

Retrieved on: 
Tuesday, February 27, 2024

Care Coordination Technology Providers Collaborate to Strengthen New York Health Initiatives in Preparation for the 1115 Medicaid Waiver Implementation

Key Points: 
  • This strategic alliance comes at a pivotal juncture with the recent approval of the New York 1115 Medicaid Waiver.
  • "Our partnership with Unite Us is more than just a collaboration; it's a fusion of strengths," said Alyza Tarmohamed, CEO at Foothold Technology.
  • Unite Us and Foothold are already collaborating with health homes across New York State, such as Coordinated Behavioral Care and Hudson Valley Care Coalition, among others.
  • "This partnership between Foothold Technology and Unite Us introduces a groundbreaking framework for our care managers and providers, enhancing how we connect and serve our community," said Pamela Mattel, CEO of Coordinated Behavioral Care.

Aledade Appoints National Equity Expert to Board of Directors

Retrieved on: 
Monday, March 11, 2024

Bethesda, MD, March 11, 2024 (GLOBE NEWSWIRE) -- Aledade , the nation’s largest network of independent primary care, has named a highly regarded diversity, equity and inclusion expert to its Board of Directors.

Key Points: 
  • Bethesda, MD, March 11, 2024 (GLOBE NEWSWIRE) -- Aledade , the nation’s largest network of independent primary care, has named a highly regarded diversity, equity and inclusion expert to its Board of Directors.
  • Joyce A. Sackey , M.D., FACP, Chief Equity, Diversity and Inclusion Officer and Associate Dean at Stanford Medicine, is the newest member of Aledade’s Board of Directors.
  • “We are grateful to have Dr. Sackey join our board and share her expertise with us,” said Farzad Mostashari, M.D., co-founder and CEO of Aledade.
  • “At Aledade, we are deeply committed to advancing equity and inclusion as part of our mission and core values.

The New York Academy of Medicine Awards 2024-2026 Jeremiah A. Barondess Fellowship in the Clinical Transaction

Retrieved on: 
Friday, March 8, 2024

Dr. Murphy’s educational intervention supported by the Fellowship focuses on teaching residents to integrate social determinants of health (SDoH) into clinical reasoning and developing patient-centered plans.

Key Points: 
  • Dr. Murphy’s educational intervention supported by the Fellowship focuses on teaching residents to integrate social determinants of health (SDoH) into clinical reasoning and developing patient-centered plans.
  • The Barondess Fellowship is awarded to junior faculty members in internal medicine to enhance medical students’ and residents’ training in the clinical transaction, a fundamental element of clinical care.
  • Dr. Murphy is an Assistant Professor of Medicine and Pediatrics at the Johns Hopkins University School of Medicine (JHUSOM).
  • She plans to use the Barondess Fellowship to develop a practical, patient-facing SDoH curriculum for the Osler Medical Residency Training Program at JHUSOM.

NMDP Awards 25th Annual ‘Amy Scholars’ Grant, Furthering Post-Transplant Research

Retrieved on: 
Wednesday, March 6, 2024

Cieri and Sacirbegovic in their research efforts to improve the lives of those battling blood cancers and blood disorders.

Key Points: 
  • Cieri and Sacirbegovic in their research efforts to improve the lives of those battling blood cancers and blood disorders.
  • We are especially grateful to the Moore family, who generously funded the Amy Scholars Research Program in 2024,” said Joy King, Chief Advancement Officer, NMDP, and Executive Director, NMDP.
  • Since 1998, NMDP has invested more than $12 million, funding 51 early-career investigators and helping them develop research portfolios and establish their laboratories.
  • “For years, we have supported groundbreaking research by collaborating with an extensive network of physicians and scientists in impacting outcomes.

Sutter Health and Charles R. Drew University Partner to Address Physician Shortage and Health Inequities Across California

Retrieved on: 
Wednesday, March 6, 2024

"This unique collaboration marks a significant step toward building a more equitable health care system in California,” said Dr. David M. Carlisle, president and CEO of Charles R. Drew University.

Key Points: 
  • "This unique collaboration marks a significant step toward building a more equitable health care system in California,” said Dr. David M. Carlisle, president and CEO of Charles R. Drew University.
  • Additionally, it will fund HEARE over the next five years to help accelerate interventions that address root causes of inequities.
  • Sutter Health and CDU will also explore additional opportunities to broaden the partnership and train more physicians with future initiatives.
  • This investment is part of Sutter’s broader commitment to address California’s growing physician shortage and persistent health inequities by enhancing access to culturally competent care for under-represented populations.

Season Health Announces Partnership with Steward Health Care Network, Providing Food-as-Medicine Programs to Address Hypertension and Nutrition Insecurity

Retrieved on: 
Tuesday, March 5, 2024

Austin, TX, March 05, 2024 (GLOBE NEWSWIRE) -- Season Health, the leading food-as-medicine platform designed to address chronic condition management at scale, today announced a partnership with Steward Health Care Network, the largest physician-led private for-profit health care network in the United States.

Key Points: 
  • Austin, TX, March 05, 2024 (GLOBE NEWSWIRE) -- Season Health, the leading food-as-medicine platform designed to address chronic condition management at scale, today announced a partnership with Steward Health Care Network, the largest physician-led private for-profit health care network in the United States.
  • The partnership includes two comprehensive programs in Massachusetts: the first is focused on patients with hypertension and the second supports Medicaid patients with chronic conditions who are experiencing nutrition insecurity.
  • “This partnership with Season reflects our commitment to meeting the nutrition needs of our members and addressing health equity for our members across Massachusetts,” said Jennie Vital, Director, Medicaid ACO at Steward.
  • “Season's evidence-based programs ensure that clinical care and medically-tailored food are both affordable and accessible, supporting improved outcomes for our members.”

Wisconsin's Drive for $75M Towards Personalized Medicine Innovation

Retrieved on: 
Thursday, February 29, 2024

Image-Guided Therapy Data-Centric Patient Care Pathway- streamlines the integration of new technologies into healthcare systems, supporting the growth of theranostics and driving innovation in personalized medicine.

Key Points: 
  • Image-Guided Therapy Data-Centric Patient Care Pathway- streamlines the integration of new technologies into healthcare systems, supporting the growth of theranostics and driving innovation in personalized medicine.
  • Wisconsin Biohealth Tech Hub Governance- nurtures collaboration across projects, tracks metrics, and shares learnings, reinforcing the cycle of innovation and deployment.
  • "Receiving the Tech Hub designation was just the beginning," explains Wendy Harris , Regional Innovation Officer for the Wisconsin Biohealth Tech Hub .
  • "It recognizes Wisconsin's strengths in personalized medicine, biohealth technology, and precision manufacturing.

Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day

Retrieved on: 
Thursday, February 29, 2024

SOUTH SAN FRANCISCO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is joining the European Organisation for Rare Diseases (EURORDIS) and the National Organization for Rare Disorders (NORD) to recognize Rare Disease Day®.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is joining the European Organisation for Rare Diseases (EURORDIS) and the National Organization for Rare Disorders (NORD) to recognize Rare Disease Day®.
  • Rare Disease Day® is an international campaign elevating the awareness and public understanding of rare diseases.
  • The initiative spotlights the more than 300 million people worldwide living with a rare disease, and the awareness efforts focused on bringing them more equitable access to diagnosis, treatment, care and social opportunity.
  • “We are proud to be joining EURORDIS, NORD and countless others worldwide to recognize Rare Disease Day and stand in support of those who bravely navigate the complexities and challenges of rare diseases," said Robert I. Blum, Cytokinetics’ President and Chief Executive Officer.

WW International, Inc. Announces Upcoming Oprah Winfrey Board Transition

Retrieved on: 
Wednesday, February 28, 2024

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) announced today that Director Oprah Winfrey has decided not to stand for re-election at the Company’s upcoming annual meeting of shareholders to be held in May 2024. Ms. Winfrey has served on the Company’s Board of Directors since 2015.  

Key Points: 
  • NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) announced today that Director Oprah Winfrey has decided not to stand for re-election at the Company’s upcoming annual meeting of shareholders to be held in May 2024.
  • Ms. Winfrey has served on the Company’s Board of Directors since 2015.
  • In addition, Ms. Winfrey intends to donate the proceeds from any future exercises of her WW stock options to NMAAHC.
  • What I know for sure, we will dearly miss her presence on the Board,” said Thilo Semmelbauer, Chairman of the Board.